Mi-Young Kim

Dr. Mi-Young Kim


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in Molecules and Cells
Verified
Journal Article
Open access
PDF file
MKMi-Young Kim
Mi-Young Kim
AKAnnie J. Kruger
Annie J. Kruger
JJJu-Yeon Jeong
Ju-Yeon Jeong
JKJaehee Kim
Jaehee Kim
PSPhil-Kyung Shin
Phil-Kyung Shin
SHSung Pyo Hong
Sung Pyo Hong
Mi-Young Kim, Annie J. Kruger, Ju-Yeon Jeong, Jaehee Kim, Phil kyung Shin, Sun Young Kim, Joo Young Cho, Ki Baik Hahm, and Sung Pyo Hong. Mol. Cells 2019;42:448-59. https://doi.org/10.14348/molcells.2019.2395

1 January 2021 in Nutrition Research and Practice
Verified
Journal Article
Open access
PDF file
MKMi-Young Kim
Mi-Young Kim
SCSang Woon Choi
Sang Woon Choi
Kim MY, et al. Nutr Res Pract. 2021 Aug;15(4):411-430. https://doi.org/10.4162/nrp.2021.15.4.411

1 April 2018 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
KKKwang-Soo Kim
Kwang-Soo Kim
JKJiewan Kim
Jiewan Kim
NONuri Oh
Nuri Oh
MKMi-Young Kim
Mi-Young Kim
Kyung-soon ParkKyung-soon Park
Kyung-soon Park

28 December 2020 in Applied Sciences
Verified
Journal Article
Open access
PDF file
MKMi-Young Kim
Mi-Young Kim
SCSang Woon Choi
Sang Woon Choi
Walnut contains many nutrients and bioactive components such as essential fatty acids, polyphenols, fiber, ɤ-tocopherol, folate, minerals, and vegetable protein, and has therefore been regarded as a natural functional food. Walnut-enriched diets have been demonstrated to be useful for heart health, cancer prevention, and metabolic disorders owing to their anti-oxidative and anti-inflammatory properties as well as for the maintenance of a healthy metabolism and immune function. Walnut extracts, either phenolic or lipid, also demonstrated the health effects in animal and cultured cell studies. More recently, the beneficial effects of walnut consumption on non-alcoholic fatty liver disease, which is a hepatic manifestation of obesity, hyperlipidemia, type 2 diabetes mellitus, and metabolic syndrome with substantial hepatic accumulation of triglyceride, have been proposed because walnut and a walnut-containing diet can modulate the etiologic mechanism such as ameliorating systemic and hepatic dyslipidemia, reducing lipotoxicity and inflammation, enhancing immune function, and maintaining gut microbiota balance. Through the extensive literature review we discuss the preventive roles of walnut in the development and progression of non-alcoholic fatty liver disease (NAFLD) and provide mechanistic insights into these effects.

13 September 2025 in European Journal of Cancer
Verified
Journal Article
Open access
YKYohan Kim
Yohan Kim
EKEun Young Kim
Eun Young Kim
MKMi-Young Kim
Mi-Young Kim
BCBaek Hwan Cho
Baek Hwan Cho
Current screening strategies for colorectal cancer (CRC) rely on colonoscopy, an invasive procedure with limited capacity to address individual risk. There is growing interest in integrating noninvasive immune biomarkers to improve early detection of precancerous colorectal neoplasia (CRN) in asymptomatic individuals. This study aimed to evaluate the predictive utility of immune-related markers, particularly natural killer cell activity (NKA), in enhancing risk stratification through machine learning approaches. Data from 6146 asymptomatic adults who underwent colonoscopy and immune biomarker testing during routine health evaluations were retrospectively analyzed. A range of machine learning models were developed and evaluated via stratified cross-validation. Additional analyses included longitudinal follow-up of false-positive cases and ablation study to evaluate the importance of immune-related variables. Sex-stratified analyses were conducted. Integration of immune biomarkers improved prediction of precancerous CRN, with TabNet achieving an area under the curve (AUC) of 0.734 for advanced neoplasms and 0.739 for high risk polyps. Models demonstrated high negative predictive value, supporting their utility for screening triage. Individuals misclassified as having advanced neoplasm despite normal colonoscopy findings exhibited a significantly elevated prevalence of neoplasia on follow-up. Removal of immune variables led to substantial declines in model performance. Notably, the predictive value of NKA was stronger in females, indicating sex-specific immunological dynamics. Immune-informed machine learning models provide a noninvasive and individualized strategy for CRC screening. The findings support the clinical value of incorporating immune markers, particularly NKA, into risk stratification frameworks and highlight the need for sex-specific approaches in surveillance planning.

15 June 2022 in Cancer Research
Verified
Journal Article
Open access
SBSeungtae Baek
Seungtae Baek
SISun-Kyoung Im
Sun-Kyoung Im
MLMinji Lee
Minji Lee
MJMankyu Ji
Mankyu Ji
MKMi-Young Kim
Mi-Young Kim
DCDonghoon Choi
Donghoon Choi
RhIL-7-hyFc (efineptakin-alfa; NT-I7) is a potent T cell amplifier, with a homodimeric interleukin-7 (IL-7) fused to the hybridizing IgD/IgG4 immunoglobulin domain. Previous work has shown that in mice, NT-I7 dramatically increases tumor-infiltrating CD8+ T cells while reducing the frequency of PD-1+ CD8+ T cells in the tumor. There is also significant expansion of Central Memory (CM)-phenotype CD8+ T cells (CD62L+CD44+) in the tumor and tumor draining lymph node. Here, we investigated the anti-tumor effect of NT-I7 in combination with a T cell activator, SLC-3010 (hIL-2/TCB2c complex), in MC38 tumor-bearing mice. Because TCB2 is an antibody specific for IL-2 that blocks interaction of IL-2 and IL-2Rα (CD25), SLC-3010 can selectively activate T cells while disfavoring Treg activation. Mice were administered a single dose of NT-I7 or SLC-3010 via intramuscular or intravenous injection, respectively. The combination of NT-I7 with SLC-3010 enhanced the anti-tumor response with increased number and frequency of CD8+ T cells as well as granzyme B expression in the tumor. The number of CD8+ T cells peaked at day 4 and day 7 by SLC-3010 and NT-I7, respectively. The number of Tregs in the tumor was slightly increased by NT-I7 and SLC-3010, but it was not statistically significant. Interestingly, NT-I7, but not SLC-3010, increased the frequency of PD-1+TCF-1+TOX- stem-like CD8+ T cells in the draining lymph node. Meanwhile, SLC-3010 significantly increased the number of PD-1+ CD8+ T cells in the tumor. Our data suggests that NT-I7 can be applied in combination with other immunotherapies such as IL-2 to enhance the anti-tumor response. Citation Format: Seungtae Baek, Sun-Kyoung Im, Minji Lee, Mankyu Ji, Miyoung Kim, Daeun Kim, Jun Young Lee, Donghoon Choi. rhIL-7-hyFc (efineptakinalpha; NT-I7) enhances the anti-tumor response when combined with hIL-2/TCB2c complex [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 4199.